Mon, Dec 29, 2014, 9:01 AM EST - U.S. Markets open in 29 mins.


% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • robbie1165 robbie1165 Jul 29, 2013 5:23 PM Flag

    Rare dieases, hmmmm...

    Pfizer to Reorganize Into 3 Business Segments

    By Dan Radovsky | More Articles | Save For Later
    July 29, 2013 | Comments (0)

    Pfizer (NYSE: PFE ) plans to internally separate its commercial operations into three separate business segments, the company announced today. Two of those segments will include what the company calls innovative business lines, and a third will include its value lines.

    One of the innovative segments will include products that cover several therapeutic areas, including inflammation and immunology, CV/metabolic, neuroscience and pain, rare diseases, and women's and men's health. Those products will have market exclusivity beyond 2015

1.83Dec 26 4:02 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.